{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:37:27Z","timestamp":1787956647779,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11764-024-01555-w","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:14:44Z","timestamp":1710278084000},"page":"1325-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Optimization of mHealth behavioral interventions for patients with chronic lymphocytic leukemia: the HEALTH4CLL study"],"prefix":"10.1007","volume":"19","author":[{"given":"Che Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Markofski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"LaVoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Basen-Engquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"issue":"5","key":"1555_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1056\/NEJMra1908213","volume":"383","author":"JA Burger","year":"2020","unstructured":"Burger JA. Treatment of chronic lymphocytic leukemia. N Engl J Med. 2020;383(5):460\u201373.","journal-title":"N Engl J Med"},{"issue":"12","key":"1555_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","volume":"370","author":"V Goede","year":"2014","unstructured":"Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner CM, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014;370(12):1101\u201310.","journal-title":"N Engl J Med"},{"issue":"5","key":"1555_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa1817073","volume":"381","author":"TD Shanafelt","year":"2019","unstructured":"Shanafelt TD, Wang XV, Kay NE, Hanson CA, O\u2019Brien S, Barrientos J, et al. Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia. N Engl J Med. 2019;381(5):432\u201343.","journal-title":"N Engl J Med"},{"issue":"3","key":"1555_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1182\/blood-2015-09-667675","volume":"127","author":"PA Thompson","year":"2016","unstructured":"Thompson PA, Tam CS, O\u2019Brien SM, Wierda WG, Stingo F, Plunkett W, et al. Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia. Blood. 2016;127(3):303\u20139.","journal-title":"Blood"},{"issue":"25","key":"1555_CR5","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745\u201360.","journal-title":"Blood"},{"issue":"26","key":"1555_CR6","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910\u20136.","journal-title":"N Engl J Med"},{"issue":"15","key":"1555_CR7","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1002\/cncr.31554","volume":"124","author":"MJ Gordon","year":"2018","unstructured":"Gordon MJ, Churnetski M, Alqahtani H, Rivera X, Kittai A, Amrock SM, et al. Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib. Cancer. 2018;124(15):3192\u2013200.","journal-title":"Cancer"},{"issue":"4","key":"1555_CR8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/bjh.16879","volume":"192","author":"MJ Gordon","year":"2021","unstructured":"Gordon MJ, Huang J, Chan RJ, Bhargava P, Danilov AV. Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials. Br J Haematol. 2021;192(4):720\u20138.","journal-title":"Br J Haematol"},{"issue":"17","key":"1555_CR9","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-20-3993","volume":"27","author":"MJ Gordon","year":"2021","unstructured":"Gordon MJ, Kaempf A, Sitlinger A, Shouse G, Mei M, Brander DM, et al. The chronic lymphocytic leukemia comorbidity index (CLL-CI): A three-factor comorbidity model. Clin Cancer Res. 2021;27(17):4814\u201324.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1555_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219\u201334.","journal-title":"Blood"},{"issue":"26","key":"1555_CR11","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/blood-2017-03-772285","volume":"129","author":"GM Rigolin","year":"2017","unstructured":"Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, et al. In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI. Blood. 2017;129(26):3495\u20138.","journal-title":"Blood"},{"issue":"9","key":"1555_CR12","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1038\/s41375-021-01156-x","volume":"35","author":"EC Rotbain","year":"2021","unstructured":"Rotbain EC, Niemann CU, Rostgaard K, da Cunha-Bang C, Hjalgrim H, Frederiksen H. Mapping comorbidity in chronic lymphocytic leukemia: Impact of individual comorbidities on treatment, mortality, and causes of death. Leukemia. 2021;35(9):2570\u201380.","journal-title":"Leukemia"},{"issue":"3","key":"1555_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/bjh.14785","volume":"178","author":"P Strati","year":"2017","unstructured":"Strati P, Parikh SA, Chaffee KG, Kay NE, Call TG, Achenbach SJ, et al. Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): A prospective cohort study. Br J Haematol. 2017;178(3):394\u2013402.","journal-title":"Br J Haematol"},{"issue":"5","key":"1555_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","volume":"131","author":"GA Abel","year":"2018","unstructured":"Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018;131(5):515\u201324.","journal-title":"Blood"},{"issue":"4","key":"1555_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3109\/10428194.2015.1091933","volume":"57","author":"V Goede","year":"2016","unstructured":"Goede V, Bahlo J, Chataline V, Eichhorst B, D\u00fcrig J, Stilgenbauer S, et al. Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group. Leuk Lymphoma. 2016;57(4):789\u201396.","journal-title":"Leuk Lymphoma"},{"key":"1555_CR16","unstructured":"U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary guidelines for Americans. 2010. 7th Edition 2010 [Available from: https:\/\/health.gov\/sites\/default\/files\/2020-01\/DietaryGuidelines2010.pdf."},{"issue":"11","key":"1555_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375\u201390.","journal-title":"Med Sci Sports Exerc"},{"key":"1555_CR18","first-page":"Cd008465","volume":"8","author":"SI Mishra","year":"2012","unstructured":"Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;8:Cd008465.","journal-title":"Cochrane Database Syst Rev"},{"issue":"27","key":"1555_CR19","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1200\/JCO.2008.20.0634","volume":"27","author":"KS Courneya","year":"2009","unstructured":"Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27(27):4605\u201312.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1555_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/annonc\/mdt568","volume":"25","author":"F Streckmann","year":"2014","unstructured":"Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G, et al. Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol. 2014;25(2):493\u20139.","journal-title":"Ann Oncol"},{"issue":"8","key":"1555_CR21","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/bloodadvances.2019001317","volume":"4","author":"A Sitlinger","year":"2020","unstructured":"Sitlinger A, Brander DM, Bartlett DB. Impact of exercise on the immune system and outcomes in hematologic malignancies. Blood Adv. 2020;4(8):1801\u201311.","journal-title":"Blood Adv"},{"key":"1555_CR22","doi-asserted-by":"publisher","first-page":"933619","DOI":"10.3389\/fonc.2022.933619","volume":"12","author":"A Sitlinger","year":"2022","unstructured":"Sitlinger A, Deal MA, Garcia E, Connelly M, Thompson D, Stewart T, et al. Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia. Front Oncol. 2022;12:933619.","journal-title":"Front Oncol"},{"key":"1555_CR23","doi-asserted-by":"crossref","unstructured":"Sitlinger A, Deal MA, Garcia E, Thompson DK, Stewart T, MacDonald GA, et al. Physiological fitness and the pathophysiology of chronic lymphocytic leukemia (CLL). Cells. 2021;10(5).","DOI":"10.3390\/cells10051165"},{"issue":"3","key":"1555_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11764-020-00855-1","volume":"14","author":"SS Coughlin","year":"2020","unstructured":"Coughlin SS, Caplan LS, Stone R. Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: A review of health intervention studies. J Cancer Surviv. 2020;14(3):386\u201392.","journal-title":"J Cancer Surviv"},{"issue":"6","key":"1555_CR25","doi-asserted-by":"publisher","first-page":"e16112","DOI":"10.2196\/16112","volume":"22","author":"K Furness","year":"2020","unstructured":"Furness K, Sarkies MN, Huggins CE, Croagh D, Haines TP. Impact of the method of delivering electronic health behavior change interventions in survivors of cancer on engagement, health behaviors, and health outcomes: Systematic review and meta-analysis. J Med Internet Res. 2020;22(6):e16112.","journal-title":"J Med Internet Res"},{"issue":"6","key":"1555_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s11764-017-0632-1","volume":"11","author":"AL Roberts","year":"2017","unstructured":"Roberts AL, Fisher A, Smith L, Heinrich M, Potts HWW. Digital health behaviour change interventions targeting physical activity and diet in cancer survivors: A systematic review and meta-analysis. J Cancer Surviv. 2017;11(6):704\u201319.","journal-title":"J Cancer Surviv"},{"issue":"1","key":"1555_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11764-020-00913-8","volume":"15","author":"N Fareed","year":"2021","unstructured":"Fareed N, Swoboda CM, Jonnalagadda P, Huerta TR. Persistent digital divide in health-related internet use among cancer survivors: Findings from the Health Information National Trends Survey, 2003\u20132018. J Cancer Surviv. 2021;15(1):87\u201398.","journal-title":"J Cancer Surviv"},{"key":"1555_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12029-018-0128-x","volume":"50","author":"AB Sanders","year":"2019","unstructured":"Sanders AB, Conroy DE, Schmitz KH, Gusani N. Physical activity and sedentary behavior in older gastrointestinal cancer survivors: need and acceptability of digital health interventions. J Gastrointest Cancer. 2019;50:703\u20138.","journal-title":"J Gastrointest Cancer."},{"key":"1555_CR29","doi-asserted-by":"crossref","unstructured":"Collins LM. Optimization of behavioral, biobehavioral, and biomedical interventions: the multiphase optimization strategy (MOST): Springer International Publishing. 2018.","DOI":"10.1007\/978-3-319-72206-1"},{"key":"1555_CR30","doi-asserted-by":"crossref","unstructured":"The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care. 2002;25(12):2165\u201371.","DOI":"10.2337\/diacare.25.12.2165"},{"issue":"3","key":"1555_CR31","first-page":"230","volume":"72","author":"CL Rock","year":"2022","unstructured":"Rock CL, Thomson CA, Sullivan KR, Howe CL, Kushi LH, Caan BJ, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. 2022;72(3):230\u201362.","journal-title":"CA Cancer J Clin"},{"key":"1555_CR32","unstructured":"Haahr M. Random.org: True random number service 2006 [Available from: http:\/\/www.random.org."},{"issue":"2","key":"1555_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63\u201374.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"1555_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jclinepi.2006.06.025","volume":"61","author":"M Rose","year":"2008","unstructured":"Rose M, Bjorner JB, Becker J, Fries JF, Ware JE. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2008;61(1):17\u201333.","journal-title":"J Clin Epidemiol"},{"key":"1555_CR35","unstructured":"Rikli RE, Jones CJ. Senior fitness test manual: Human kinetics. 2013."},{"key":"1555_CR36","unstructured":"PROMIS scale - Global health [Available from: https:\/\/www.healthmeasures.net\/index.php?option=com_instruments&view=measure&id=778&Itemid=992."},{"issue":"1","key":"1555_CR37","first-page":"18","volume":"4","author":"G Godin","year":"2011","unstructured":"Godin G. The Godin-Shephard leisure-time physical activity questionnaire. Health Fitness J Canada. 2011;4(1):18\u201322.","journal-title":"Health Fitness J Canada"},{"issue":"9","key":"1555_CR38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","volume":"118","author":"SM Krebs-Smith","year":"2018","unstructured":"Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the Healthy Eating Index: HEI-2015. J Acad Nutr Diet. 2018;118(9):1591\u2013602.","journal-title":"J Acad Nutr Diet"},{"issue":"8","key":"1555_CR39","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1182\/bloodadvances.2021005716","volume":"6","author":"EC Rotbain","year":"2022","unstructured":"Rotbain EC, Gordon MJ, Vainer N, Frederiksen H, Hjalgrim H, Danilov AV, et al. The CLL comorbidity index in a population-based cohort: A tool for clinical care and research. Blood Adv. 2022;6(8):2701\u20136.","journal-title":"Blood Adv"},{"issue":"11","key":"1555_CR40","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/bloodadvances.2022009507","volume":"7","author":"MJ Gordon","year":"2023","unstructured":"Gordon MJ, Duan Z, Zhao H, Nastoupil LJ, Ferrajoli A, Danilov AV, et al. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale. Blood Adv. 2023;7(11):2632\u201342.","journal-title":"Blood Adv."},{"issue":"2","key":"1555_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12160-010-9253-x","volume":"41","author":"LM Collins","year":"2011","unstructured":"Collins LM, Baker TB, Mermelstein RJ, Piper ME, Jorenby DE, Smith SS, et al. The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med. 2011;41(2):208\u201326.","journal-title":"Ann Behav Med"},{"issue":"01","key":"1555_CR42","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1007\/s10461-015-1145-4","volume":"20","author":"LM Collins","year":"2016","unstructured":"Collins LM, Kugler KC, Gwadz MV. Optimization of multicomponent behavioral and biobehavioral interventions for the prevention and treatment of HIV\/AIDS. AIDS Behav. 2016;20(01):S197-214.","journal-title":"AIDS Behav"},{"issue":"2","key":"1555_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3945\/ajcn.2008.26566","volume":"89","author":"JO Hill","year":"2009","unstructured":"Hill JO. Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council. Am J Clin Nutr. 2009;89(2):477\u201384.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1555_CR44","doi-asserted-by":"publisher","first-page":"23137","DOI":"10.1038\/s41598-021-02352-6","volume":"11","author":"G MacDonald","year":"2021","unstructured":"MacDonald G, Sitlinger A, Deal MA, Hanson ED, Ferraro S, Pieper CF, et al. A pilot study of high-intensity interval training in older adults with treatment na\u00efve chronic lymphocytic leukemia. Sci Rep. 2021;11(1):23137.","journal-title":"Sci Rep"},{"issue":"6","key":"1555_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1200\/JCO.2008.17.5026","volume":"27","author":"KM Bellizzi","year":"2009","unstructured":"Bellizzi KM, Rowland JH, Arora NK, Hamilton AS, Miller MF, Aziz NM. Physical activity and quality of life in adult survivors of non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2009;27(6):960\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01555-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:14:38Z","timestamp":1757099678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01555-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01555-w","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"27 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the MD Anderson Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}